SWS Hemodialysis Care Co., Ltd.

XSSC:688410 Stock Report

Market Cap: CN¥3.7b

SWS Hemodialysis Care Past Earnings Performance

Past criteria checks 1/6

SWS Hemodialysis Care has been growing earnings at an average annual rate of 45.8%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 26.6% per year. SWS Hemodialysis Care's return on equity is 4.2%, and it has net margins of 14.1%.

Key information

45.8%

Earnings growth rate

44.9%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate26.6%
Return on equity4.2%
Net Margin14.1%
Next Earnings Update22 Apr 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How SWS Hemodialysis Care makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

XSSC:688410 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 245327517153
30 Jun 2457310616750
31 Mar 2465915417144
31 Dec 2369019416438
30 Sep 2369820715132
30 Jun 2362317613527
31 Mar 2350812611725
31 Dec 223825910123
30 Sep 223535011921
30 Jun 22305338519
31 Mar 22284258017
31 Dec 21283198218
31 Dec 20254217617
31 Dec 19142-346412
31 Dec 18114-27609
30 Jun 18105-7541
31 Mar 1894-10530
31 Dec 1785-4480
30 Sep 17870444
30 Jun 17884424
31 Mar 17865440
31 Dec 16875450
30 Sep 16762410
30 Jun 16660370
31 Mar 16611360
31 Dec 15572340

Quality Earnings: 688410 has a large one-off gain of CN¥17.3M impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: 688410's current net profit margins (14.1%) are lower than last year (29.6%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 688410 has become profitable over the past 5 years, growing earnings by 45.8% per year.

Accelerating Growth: 688410's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 688410 had negative earnings growth (-63.8%) over the past year, making it difficult to compare to the Medical Equipment industry average (-8.8%).


Return on Equity

High ROE: 688410's Return on Equity (4.2%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 02:29
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

SWS Hemodialysis Care Co., Ltd. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhu ChenCitic Securities Co., Ltd.